S100A4 Protein in Inflammatory Bowel Disease: Results of a Single Centre Prospective Study
Identifikátory výsledku
Kód výsledku v IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11150%2F17%3A10375153" target="_blank" >RIV/00216208:11150/17:10375153 - isvavai.cz</a>
Nalezeny alternativní kódy
RIV/00179906:_____/17:10375153
Výsledek na webu
<a href="https://actamedica.lfhk.cuni.cz/60/3/0108/" target="_blank" >https://actamedica.lfhk.cuni.cz/60/3/0108/</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.14712/18059694.2018.2" target="_blank" >10.14712/18059694.2018.2</a>
Alternativní jazyky
Jazyk výsledku
angličtina
Název v původním jazyce
S100A4 Protein in Inflammatory Bowel Disease: Results of a Single Centre Prospective Study
Popis výsledku v původním jazyce
Introduction: The aim of our study was to assess association of serum S100A4 protein with ulcerative colitis (UC) and Crohn's disease (CD). Methods: Study included 118 subjects: 93 patients with CD, 16 with UC and 9 controls. In CD group, 20/93 patients had B1 phenotype, 19/93 B2, 20/93 B3 and 34/93 B2 + B3. L1 involvement was present in 15/93, L2 in 14/93 and L3 in 64/93 patients. Serum S100A4 concentration was investigated in peripheral venous blood samples by means of ELISA. Results: Serum S100A4 was significantly higher in UC (158.6 +- 56.2 ng/mL), p = 0.019 and in CD (154.4 +- 52.1 ng/mL), p = 0.007 compared to controls (104.8 +- 40.5 ng/mL). No difference in S100A4 was revealed between UC and CD, p > 0.05. Serum S100A4 in each CD subgroup (according to behaviour) was significantly higher compared to controls, p < 0.05. Serum S100A4 was significantly higher in L2 (144.6 +- 44.2 ng/mL), p = 0.041 and in L3 (163.0 +- 52.8 ng/mL), p = 0.002 compared to controls and in L3 compared to L1 (126.9 +- 47.6 ng/mL), p = 0.017. Conclusion: Association of serum S100A4 protein with UC and CD was confirmed. In CD, disease behaviour did not influence serum concentration of S100A4 protein. In CD, higher levels of serum S100A4 were observed in patients with ileo-colonic and colonic involvement compared to those with isolated small bowel involvement.
Název v anglickém jazyce
S100A4 Protein in Inflammatory Bowel Disease: Results of a Single Centre Prospective Study
Popis výsledku anglicky
Introduction: The aim of our study was to assess association of serum S100A4 protein with ulcerative colitis (UC) and Crohn's disease (CD). Methods: Study included 118 subjects: 93 patients with CD, 16 with UC and 9 controls. In CD group, 20/93 patients had B1 phenotype, 19/93 B2, 20/93 B3 and 34/93 B2 + B3. L1 involvement was present in 15/93, L2 in 14/93 and L3 in 64/93 patients. Serum S100A4 concentration was investigated in peripheral venous blood samples by means of ELISA. Results: Serum S100A4 was significantly higher in UC (158.6 +- 56.2 ng/mL), p = 0.019 and in CD (154.4 +- 52.1 ng/mL), p = 0.007 compared to controls (104.8 +- 40.5 ng/mL). No difference in S100A4 was revealed between UC and CD, p > 0.05. Serum S100A4 in each CD subgroup (according to behaviour) was significantly higher compared to controls, p < 0.05. Serum S100A4 was significantly higher in L2 (144.6 +- 44.2 ng/mL), p = 0.041 and in L3 (163.0 +- 52.8 ng/mL), p = 0.002 compared to controls and in L3 compared to L1 (126.9 +- 47.6 ng/mL), p = 0.017. Conclusion: Association of serum S100A4 protein with UC and CD was confirmed. In CD, disease behaviour did not influence serum concentration of S100A4 protein. In CD, higher levels of serum S100A4 were observed in patients with ileo-colonic and colonic involvement compared to those with isolated small bowel involvement.
Klasifikace
Druh
J<sub>SC</sub> - Článek v periodiku v databázi SCOPUS
CEP obor
—
OECD FORD obor
30219 - Gastroenterology and hepatology
Návaznosti výsledku
Projekt
—
Návaznosti
S - Specificky vyzkum na vysokych skolach<br>I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Ostatní
Rok uplatnění
2017
Kód důvěrnosti údajů
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Údaje specifické pro druh výsledku
Název periodika
Acta Medica (Hradec Králové)
ISSN
1211-4286
e-ISSN
—
Svazek periodika
60
Číslo periodika v rámci svazku
3
Stát vydavatele periodika
CZ - Česká republika
Počet stran výsledku
6
Strana od-do
108-113
Kód UT WoS článku
—
EID výsledku v databázi Scopus
2-s2.0-85046283311